UK Study to Test Pfizer’s COVID Pill in Hospitalized Patients

Published on March 28, 2022

In a groundbreaking experiment, researchers in the UK will explore the effectiveness of Pfizer’s oral COVID-19 pill as a potential remedy for individuals admitted to hospitals due to the infection. This study comes at a crucial time when the world is once again witnessing a surge in coronavirus cases. Considered as the largest trial of its kind, it aims to assess the efficacy and safety of Pfizer’s pill in treating hospitalized patients with COVID-19. The investigation follows growing evidence that this oral medication could be a game-changer in curbing the severity of the illness and reducing hospital admissions. To ensure reliable results, scientists will employ a randomized approach where patients will be assigned either Pfizer’s pill or a placebo. Excitingly, if the trial demonstrates positive outcomes, this could lead to an enormous breakthrough in managing COVID-19. For more information on this pioneering research, dive into the details of this fascinating study!

A British trial will investigate U.S. drugmaker Pfizer’s oral COVID-19 pill as a potential treatment for patients hospitalized with the illness, scientists said on Monday, as global coronavirus cases are surging once again. The world’s largest randomized study of potential…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>